Yayınlar & Eserler

Yayın Ağı
Makaleler 110
Tümü (110)
SCI-E, SSCI, AHCI (86)
SCI-E, SSCI, AHCI, ESCI (103)
ESCI (11)
Scopus (110)
TRDizin (26)

1. The first outbreak of neuroinvasive West Nile virus infection in Istanbul area within 2019

KAPMAZ M., Başaran S., Menemenlioğlu D., BATIREL A., Şengöz G., EROL S., et al.
BMC Infectious Diseases , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections

Aslan A. T., Ezure Y., TANRIVERDİ E. S., DAĞ O., Cimen C., KAYA KALEM A., et al.
Journal of Antimicrobial Chemotherapy , cilt.81, sa.6, 2026 (SCI-Expanded, Scopus)

3. Theses on Healthcare-Associated Infections and Their Publication Conversion Rates

Arslan M., Karakök T., Akgül F., BATIREL A., Keske Ş., Ergönül Ö.
Infectious Diseases and Clinical Microbiology , cilt.8, sa.3, ss.295-300, 2026 (ESCI, Scopus, TRDizin) Creative Commons License

4. Cancer prevalence and prognosis among individuals living with HIV and AIDS in Turkey: Multicenter BUHASDER study

GÜLER Ö., AKHAN S., Çağatay A., BATIREL A., SARGIN ALTUNOK E., Bolukçu S., et al.
International Journal of STD and AIDS , cilt.37, sa.5, ss.500-510, 2026 (SCI-Expanded, Scopus)

5. Causes of death in people living with human immunodeficiency virus in Türkiye: a multicentre retrospective study

Sayın Kutlu S., GÜLTEN E., ALTUNSOY A., NAZLI A., ALTUNAL L. N., Taşdelen Fışgın N., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.45, sa.3, ss.767-776, 2026 (SCI-Expanded, Scopus)

6. Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from Türkiye (2004–2024)

Çiçek Y., DUMLU R., KOÇAK M., Pirdal B. Z., Çelik M., SALTOĞLU N., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.45, sa.2, ss.537-555, 2026 (SCI-Expanded, Scopus)

7. Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye

Gunduz A., ÖZTOPRAK ÇUVALCI N., SARI N. D., Kurtaran B., ÖNLEN Y., Senates E., et al.
Turkish Journal of Gastroenterology , cilt.37, sa.6, ss.673-681, 2026 (SCI-Expanded, Scopus, TRDizin)

8. Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3

Kaya S. Y., Kurtaran B., Çuvalcı N. Ö., ÖNLEN Y., Ceylan M. R., Zerdali E., et al.
Turkish Journal of Gastroenterology , cilt.37, sa.1, ss.113-120, 2026 (SCI-Expanded, Scopus, TRDizin)

9. A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate

Yamazhan T., Zerdali E., ÖNLEN Y., TOSUN S., GÜNAL Ö., BATIREL A., et al.
Turkish Journal of Gastroenterology , cilt.37, sa.2, ss.179-185, 2026 (SCI-Expanded, Scopus, TRDizin)

10. Impact of the COVID-19 pandemic on surgical site infections: a multi-center study evaluating incidence, pathogen distribution, and antimicrobial resistance patterns

Keske Ş., SARGIN ALTUNOK E., Azak E., GÜLTEN E., ARSLAN GÜLEN T., ATAMAN HATİPOĞLU Ç., et al.
Antimicrobial Resistance and Infection Control , cilt.14, sa.1, 2025 (SCI-Expanded, Scopus)

11. Managing penicillin resistant pneumococcal meningitis: an international id-iri study

ERDEM H., Dogan E., ANKARALI H., Dragovac G., SEYMAN D., Tarakci A., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.44, sa.11, ss.2855-2866, 2025 (SCI-Expanded, Scopus)

12. Epidemiology and outcomes of Candida-associated osteoarticular infections: A multicentre retrospective study from Turkey

GÜLER Ö., ÜZEL M., Tepe D., AKSOY F., ÇINAR G., MEMİKOĞLU K. O., et al.
Medical Mycology , cilt.63, sa.9, 2025 (SCI-Expanded, Scopus)

13. Predictive Factors for HBsAg Seroconversion Following Acute Hepatitis B Virus Infection: A Multicenter BUHASDER Study

Caydasi O., ÖZTÜRK ENGİN D., KARAŞAHİN Ö., BATIREL A., DOLU S., TOYGAR DENİZ M., et al.
Viruses , cilt.17, sa.9, 2025 (SCI-Expanded, Scopus) Creative Commons License

14. Impact of the COVID-19 Pandemic on CLABSI Rates and Antibiotic Resistance: A Multicenter Study in Türkiye

SARGIN ALTUNOK E., Keske Ş., BATIREL A., Bilgin H., GÜLTEN E., Menekşe Ş., et al.
Infectious Diseases and Clinical Microbiology , cilt.7, sa.3, ss.273-282, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

15. Evaluation of Exposure to HAV and Vaccination Status of Chronic HBV Cases - A Nationwide Multicenter Study Kronik HBV Olgularında HAV Maruziyeti ve Aşılanma Durumunun Değerlendirilmesi - Ülke Çapında Çok Merkezli Bir Çalışma

TOSUN S., BATIREL A., Zerdali E. Y., Aydın M., Tütüncü E., PARLAK E., et al.
Viral Hepatitis Journal , cilt.31, sa.2, ss.53-58, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

16. Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014–2024) ClinSurv HIV cohort: A large case series

MERT A., Derin O., Zerdali E., Kaya A., Gül Ö., Borcak D., et al.
PLOS ONE , cilt.20, sa.8 August, 2025 (SCI-Expanded, Scopus)

17. Managing Candida auris fungemias: the results of a prospective and international study

ERDEM H., Şakir-Yildirim S., ANKARALI H., BATIREL A., Kul G., Fidan G., et al.
Antimicrobial Agents and Chemotherapy , cilt.69, sa.8, 2025 (SCI-Expanded, Scopus)

18. Emerging West Nile virus infections in Türkiye

Alhan Ö., Koç M. M., BATIREL A., YILMAZ E., Ersöz G., AYDIN M., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.44, sa.7, ss.1659-1666, 2025 (SCI-Expanded, Scopus)

19. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach

DİRİCAN E., Bal T., Onlen Y., Sarigul F., User U., SARI N. D., et al.
Journal of Clinical Laboratory Analysis , cilt.39, sa.12, 2025 (SCI-Expanded, Scopus)

20. Is asynchronous telerehabilitation equal to synchronous telerehabilitation in COVID-19 survivors with classes 4–6?

Tanhan A., YILDIZ ÖZER A., TİMURTAŞ E., BATIREL A., POLAT M. G.
Journal of Telemedicine and Telecare , cilt.31, sa.3, ss.347-358, 2025 (SCI-Expanded, Scopus)

21. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database

Gajdos L., Buetti N., Tabah A., Ruckly S., AKOVA M., Sjöval F., et al.
Intensive Care Medicine , cilt.51, sa.3, ss.518-528, 2025 (SCI-Expanded, Scopus)

22. Malaria in Turkey: A comprehensive analysis of diagnosis, treatment, and the impact of COVID-19, ten years after malaria elimination (2012–2023)

Şahin Ö. E., Kalay Z., SARI N. D., BATIREL A., Ersöz G., TUNCER ERTEM G., et al.
Travel Medicine and Infectious Disease , cilt.64, 2025 (SCI-Expanded, Scopus)

23. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study

Margalit I., Yahav D., Hoffman T., Tabah A., Barbier F., Singer P., et al.
Infection , cilt.52, sa.6, ss.2435-2443, 2024 (SCI-Expanded, Scopus)

24. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Loiodice A., Bailly S., Buetti N., Barbier F., Staiquly Q., Tabah A., et al.
Clinical Microbiology and Infection , cilt.30, sa.12, ss.1559-1568, 2024 (SCI-Expanded, Scopus)

25. Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study

ŞAHİN M., MERT A., EMECEN A. N., Strunjas N. P., Fasanekova L., BATIREL A., et al.
International Journal of Infectious Diseases , cilt.147, 2024 (SCI-Expanded, Scopus)

26. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data

GÜRBÜZ Y., Kocagül-çelikbaş A., ÖZTOPRAK ÇUVALCI N., AYGEN B., BATIREL A., Habiloğlu A. D., et al.
Infectious Diseases and Clinical Microbiology , cilt.6, sa.3, ss.216-224, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

27. Identifying risk factors for blood culture negative infective endocarditis: An international ID-IRI study

Filiz M., ERDEM H., ANKARALI H., Puca E., Ruch Y., Santos L., et al.
New Microbes and New Infections , cilt.60-61, 2024 (ESCI, Scopus)

28. Surgical Antimicrobial Prophylaxis Compliance in Turkey: Data from the Prospective, Observational, Multicenter Survey Including 7,978 Surgical Patients

ÇELİK EKİNCİ S., YENİLMEZ E., Akengin Öcal G., SÖNMEZER M. Ç., Tarakçı A., Aygün C., et al.
Surgical Infections , cilt.25, sa.3, ss.231-239, 2024 (SCI-Expanded, Scopus)

29. Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey

Çelen M. K., Şengel B. E., KAYA Ş., Demirtürk N., AZAP A., Pullukçu H., et al.
Journal of Infection in Developing Countries , cilt.18, sa.3, ss.441-449, 2024 (SCI-Expanded, Scopus) Creative Commons License

30. Review of Colistin Susceptibility Testing with Current Data Kolistin Duyarlılık Testlerinin Güncel Bilgiler Eşliğinde İrdelenmesi

Nadir Y., BATIREL A.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.13, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

31. The long-term effects of different telerehabilitation programs on respiratory, exercise, and activity-related parameters in COVID-19 survivors: a randomized controlled trial in Türkiye

Tanhan A., YILDIZ ÖZER A., TİMURTAŞ E., BATIREL A., POLAT M. G.
Rural and Remote Health , cilt.24, sa.4, 2024 (SCI-Expanded, SSCI, Scopus)

32. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)—based survey

Azak E., SERTÇELİK A., Ersoz G., Celebi G., ESER F., BATIREL A., et al.
Antimicrobial Resistance and Infection Control , cilt.12, sa.1, 2023 (SCI-Expanded, Scopus)

33. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study

Aslan A. T., Tabah A., Köylü B., KAYA KALEM A., AKSOY F., Erol Ç., et al.
Journal of Antimicrobial Chemotherapy , cilt.78, sa.7, ss.1757-1768, 2023 (SCI-Expanded, Scopus)

34. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

ATEŞ İ., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.
Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus) Creative Commons License

35. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Buetti N., Staiquly Q., Ruckly S., AKOVA M., Aslan A. T., Leone M., et al.
Intensive Care Medicine , cilt.49, sa.2, ss.178-190, 2023 (SCI-Expanded, Scopus)

36. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey

Yildirim F. S., User U., SARI N. D., Kurtaran B., Önlen Y., Senates E., et al.
Turkish Journal of Gastroenterology , cilt.33, sa.11, ss.971-978, 2022 (SCI-Expanded, Scopus, TRDizin)

37. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey

ÖNLEN Y., Bal T., ÇABALAK M., ÖZTOPRAK ÇUVALCI N., SARI N. D., Kurtaran B., et al.
Turkish Journal of Gastroenterology , cilt.33, sa.10, ss.862-873, 2022 (SCI-Expanded, Scopus, TRDizin)

38. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

Cag Y., ERDEM H., Gunduz M., KÖMÜR S., ANKARALI H., Ural S., et al.
European Journal of Internal Medicine , cilt.100, ss.56-61, 2022 (SCI-Expanded, Scopus)

39. Clinical follow-up of patients with HBeAg positive chronic hepatitis B infection: A long-term observational study

Arslan F., BATIREL A., Baysal N. B., VAHABOĞLU H., MERT A.
Hepatology Forum , cilt.3, sa.2, ss.57-60, 2022 (Scopus, TRDizin)

40. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

MERT A., VAHABOĞLU H., Arslan F., BATIREL A., Saraçoğlu K. T., BAŞTUĞ A., et al.
Rheumatology International , cilt.42, sa.3, ss.457-467, 2022 (SCI-Expanded, Scopus)

41. Remdesivir treatment for patients with moderate to severe COVID-19

HASANOĞLU İ., GÜNER H. R., ÇELİK İ., Kanat F., BATIREL A., Dizman G. T., et al.
Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.880-887, 2022 (SCI-Expanded, Scopus, TRDizin)

42. The value of urinalysis in predicting acute kidney injury and mortality in COVID-19 patients Діагностична цінність аналізу сечі для прогнозування гострого пошкодження нирок і смертності у пацієнтів з COVID-19

Oruc M., BATIREL A., TRABULUS S.
Ukrainian Journal of Nephrology and Dialysis , cilt.1, ss.31-42, 2022 (Scopus) Creative Commons License

43. Association of D-dimer/fibrinogen ratio with pulmonary embolism in COVID-19 patients

Topcu A. C., Yigit F., Altunyurt G. O., BATIREL A., RABUŞ M. B.
Turkish Journal of Vascular Surgery , cilt.31, sa.3, ss.134-139, 2022 (Scopus, TRDizin)

44. Does COVID-19 Increase the Risk of Central-Line-Associated Bloodstream Infections? COVID-19, Santral Venöz Kateter İlişkili Kan Dolaşımı İnfeksiyon Riskini Artırıyor mu?

SARGIN ALTUNOK E., BATIREL A., Ersöz Z., Akay-Güven D., Öztürk-Aydemir S.
Klimik Dergisi , cilt.35, sa.3, ss.191-195, 2022 (ESCI, Scopus, TRDizin) Creative Commons License

45. Association of serum uric acid level with disease severity and clinical outcomes in COVID-19 Асоціація рівня сечової кислоти сироватки крові з тяжкістю та клінічними результатами COVID-19

Oruc M., BATIREL A.
Ukrainian Journal of Nephrology and Dialysis , sa.2, ss.6-14, 2022 (Scopus)

46. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

OMMA A., BATIREL A., AYDIN M., YILMAZ KARADAĞ F., ERDEN A., KÜÇÜKŞAHİN O., et al.
Human Vaccines and Immunotherapeutics , cilt.18, sa.6, 2022 (SCI-Expanded, Scopus)

47. Demographic Characteristics and Transmission Risk Factors of Patients with Hepatitis C Virus in Turkey: The EPI-C, A Multicenter and Cross-sectional Trial Türkiye’de Hepatit C Hastalarının Demografik Karakteristikleri ve Bulaşma Risk Faktörleri: Çok Merkezli ve Kesitsel EPI-C Çalışması

Tabak F., ŞİRİN G., DEMİR M., Aladağ M., Sümer Ş., Kurtaran B., et al.
Viral Hepatitis Journal , cilt.27, sa.3, ss.109-117, 2021 (ESCI, Scopus, TRDizin)

48. Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia

Saydam F. N., ERDEM H., ANKARALI H., El-Arab Ramadan M. E., El-Sayed N. M., Civljak R., et al.
Travel Medicine and Infectious Disease , cilt.44, 2021 (SCI-Expanded, Scopus)

49. Procalcitonin may help in diagnosing bacterial infections in COVID-19 patients during high-dose steroid therapy

BATIREL A., Eser N., Korlu E., TEZCAN M. E.
Biochimica Clinica , cilt.45, sa.3, ss.327-329, 2021 (Scopus)

50. Acute Limb Ischemia in Hospitalized COVID-19 Patients

Topcu A. C., Ozturk-Altunyurt G., Akman D., BATIREL A., DEMİRHAN R.
Annals of Vascular Surgery , cilt.74, ss.88-94, 2021 (SCI-Expanded, Scopus)

51. Should CT be used for the diagnosis of RT-PCR-negative suspected COVID-19 patients?

Rona G., Arifoğlu M., Voyvoda N., BATIREL A.
Clinical Respiratory Journal , cilt.15, sa.5, ss.491-498, 2021 (SCI-Expanded, Scopus)

52. Real-world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic hepatitis C really effective?

Demirtürk N., AYGEN B., ÇELİK İ., Mıstık R., AKHAN S., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.2, ss.155-163, 2021 (SCI-Expanded, Scopus, TRDizin)

53. Shock index as a predictor of mortality among the Covid-19 patients

DOĞANAY F., Elkonca F., SEYHAN A. U., YILMAZ E., BATIREL A., Ak R.
American Journal of Emergency Medicine , cilt.40, ss.106-109, 2021 (SCI-Expanded, Scopus)

54. Distribution of Hepatitis C virus genotypes in patients diagnosed with Hepatitis C in our hospital: 2015-2018 Hastanemizde Hepatit C Tanisi Alan Hastalarda Hepatit C Virüs Genotiplerinin Daǧilimi: 2015-2018

HACISEYİTOĞLU D., Can Sarinoǧlu R., Gözalan A., BATIREL A., Söyletir G.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (ESCI, Scopus)

55. The effectiveness of hydroxychloroquine versus vydroxychloroquine plus Lopinavir/ritonavir therapy in SARSCoV- 2 Pneumonia SARS-CoV-2 Pnömonisinde Hidroksiklorokin ile Hidroksiklorokin Arti Lopinavir/Ritonavir Tedavisinin Etkinliǧi

BATIREL A., Tekin S., Batirel H., Akalan Kuyumcu Ç., BAKAN N.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (ESCI, Scopus)

56. Pulse steroid treatment for hospitalized adults with covid-19

BATIREL A., DEMİRHAN R., Eser N., Körlü E., TEZCAN M. E.
Turkish Journal of Medical Sciences , cilt.51, sa.5, ss.2248-2255, 2021 (SCI-Expanded, Scopus, TRDizin)

57. Correlation of neuroimaging and thorax CT findings in patients with COVID-19: A large single-center experience

Günbey H. P., Rona G., Adigüzel Karaoysal Ö., BATIREL A., ÖZEN BARUT B.
Turkish Journal of Medical Sciences , cilt.51, sa.6, ss.2850-2860, 2021 (SCI-Expanded, Scopus, TRDizin)

58. Bemiparin Versus Enoxaparin for Extended Thromboprophylaxis in COVID-19 Patients at High Risk of Venous Thromboembolism COVID-19'da Tromboembolizm Profilaksisinde Bemiparin ve Enoksaparinin Karşilaştirilmasi

Topçu A. C., Öztürk-Altunyurt G., Papila-Topal N., BATIREL A.
Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (ESCI, Scopus)

59. Urological infections in the developing world: an increasing problem in developed countries

BATIREL A., Regmi S. K., Singh P., MERT A., Konety B. R., Kumar R.
World Journal of Urology , cilt.38, sa.11, ss.2681-2691, 2020 (SCI-Expanded, Scopus)

60. Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

AYGEN B., Demirtürk N., YILDIZ O., Çelen M. K., Çelik İ., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.31, sa.4, ss.305-317, 2020 (SCI-Expanded, Scopus, TRDizin)

61. Evaluation of the seroprevalence of viral hepatitis and the human immunodeficiency virus among hospital workers in Turkey and the Turkish Republic of Northern Cyprus

Kalkan I. A., ÇINAR G., Mut A. N. U., KARAŞAHİN Ö., GÜRBÜZ Y., Tekin A., et al.
Hepatitis Monthly , cilt.20, sa.4, 2020 (SCI-Expanded, Scopus)

62. A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model

Diktas H., Uysal S., ERDEM H., Cag Y., Miftode E., Durmus G., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.39, sa.4, ss.689-701, 2020 (SCI-Expanded, Scopus)

63. Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study

Tanoglu A., ERDEM H., Friedland J. S., Almajid F. M., BATIREL A., Kulzhanova S., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.39, sa.3, ss.493-500, 2020 (SCI-Expanded, Scopus)

64. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study

ERDEM H., Cag Y., Gencer S., Uysal S., Karakurt Z., Harman R., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.39, sa.1, ss.45-52, 2020 (SCI-Expanded, Scopus)

65. Effect of hepatosteatosis on the virological response in Entecavir and Tenofovir therapies Hepatosteatozun entekavir ve tenofovir tedavilerinde virolojik yanıta Etkisi

Korkmaz P., Demirtürk N., BATIREL A., Tülek N., ÖZGÜLER M., Harman R., et al.
Klimik Dergisi , cilt.32, sa.3, ss.265-274, 2019 (Scopus)

66. Portraying infective endocarditis: results of multinational ID-IRI study

ERDEM H., Puca E., Ruch Y., Santos L., Ghanem-Zoubi N., Argemi X., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.38, sa.9, ss.1753-1763, 2019 (SCI-Expanded, Scopus)

67. Awareness of hepatitis b virus reactivation among physicians administering immunosuppressive treatment and related clinical practices İmmünosüpresif tedavi veren hekimlerin hepatit b virusu reaktivasyonuyla ilgili farkındalıklarının ve klinik pratiklerinin değerlendirilmesi

Korkmaz P., Demirtürk N., ÇINAR G., ÇEKEN S., AYGEN B., TOKA O., et al.
Klimik Dergisi , cilt.32, sa.2, ss.146-153, 2019 (Scopus)

68. Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015–2016 season

Tekin S., Keske S., Alan S., BATIREL A., Karakoc C., Tasdelen-Fisgin N., et al.
International Journal of Infectious Diseases , cilt.81, ss.6-9, 2019 (SCI-Expanded, Scopus)

69. Development and validation of a modified quick SOFA scale for risk assessment in sepsis syndrome

Cag Y., Karabay O., Sipahi O. R., AKSOY F., Durmus G., BATIREL A., et al.
PLoS ONE , cilt.13, sa.9, 2018 (SCI-Expanded, Scopus)

70. Influence of multidrug resistant organisms on the outcome of diabetic foot infection

SALTOĞLU N., Ergonul O., Tulek N., Yemisen M., Kadanali A., Karagoz G., et al.
International Journal of Infectious Diseases , cilt.70, ss.10-14, 2018 (SCI-Expanded, Scopus)

71. Risk factors for recurrences in patients with hepatitis C virus after achieving a sustained virological response: A multicentre study from Turkey

Arslan F., CEYLAN B., ŞAHİN A. R., GÜNAL Ö., Kayaaslan B., Uğurlu K., et al.
Infezioni in Medicina , cilt.26, sa.2, ss.133-138, 2018 (Scopus)

72. Noninvasive models to predict liver fibrosis in patients with chronic hepatitis B: A study from Turkey

Korkmaz P., Demirturk N., BATIREL A., Cem Yardimci A., Cagir U., Nemli S. A., et al.
Hepatitis Monthly , cilt.17, sa.12, 2017 (SCI-Expanded, Scopus)

73. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis

ERDEM H., ÖZTÜRK ENGİN D., Cag Y., ŞENBAYRAK S., İNAN A., KAZAK E., et al.
International Journal of Infectious Diseases , cilt.65, ss.107-109, 2017 (SCI-Expanded, Scopus)

74. Tetanus in adults: results of the multicenter ID-IRI study

TOSUN S., BATIREL A., Oluk A., AKSOY F., Puca E., Bénézit F., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.36, sa.8, ss.1455-1462, 2017 (SCI-Expanded, Scopus)

75. Miliary tuberculosis

MERT A., Arslan F., Kuyucu T., Koç E. N., YILMAZ M., TURAN D., et al.
Medicine (United States) , cilt.96, sa.5, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study

Guclu E., Ogutlu A., Karabay O., Demirdal T., Erayman I., Hosoglu S., et al.
Journal of Chemotherapy , cilt.29, sa.1, ss.19-24, 2017 (SCI-Expanded, Scopus)

77. Quality of life and related factors among chronic hepatitis B-infected patients: A multi-center study, Turkey

KARACAER Z., ÇAKIR B., ERDEM H., Ugurlu K., Durmus G., Ince N. K., et al.
Health and Quality of Life Outcomes , cilt.14, sa.1, 2016 (SCI-Expanded, SSCI, Scopus)

78. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study

ERDEM H., ŞENBAYRAK S., Meriç K., BATIREL A., Karahocagil M. K., Hasbun R., et al.
Infection , cilt.44, sa.5, ss.623-631, 2016 (SCI-Expanded, Scopus)

79. Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study

Hatipoglu M., Mutluoglu M., Turhan V., Uzun G., Lipsky B. A., Sevim E., et al.
Journal of Diabetes and its Complications , cilt.30, sa.5, ss.910-916, 2016 (SCI-Expanded, Scopus)

80. Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study

YILMAZ M., ELALDI N., BALKAN İ. İ., Arslan F., BATIREL A., Baklcl M. Z., et al.
Annals of Clinical Microbiology and Antimicrobials , cilt.15, sa.1, 2016 (SCI-Expanded, Scopus)

81. Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir

CEYLAN B., Arslan F., BATIREL A., Fincanci M., Yardimci C., Fersan E., et al.
Turkish Journal of Gastroenterology , cilt.27, sa.1, ss.42-46, 2016 (SCI-Expanded, Scopus, TRDizin)

82. Evaluation of dual therapy in real life setting in treatment-naïve Turkish patients with HCV infection: A multicenter, retrospective study

GÜRBÜZ Y., Tülek N. E., TÜTÜNCÜ E. E., Koruk S. T., AYGEN B., Demirtürk N., et al.
Balkan Medical Journal , cilt.33, sa.1, ss.18-26, 2016 (SCI-Expanded, Scopus, TRDizin)

83. Comparison of brucellar and tuberculous spondylodiscitis patients: Results of the multicenter "backbone-1 Study"

ERDEM H., ELALDI N., BATIREL A., Aliyu S., Sengoz G., Pehlivanoglu F., et al.
Spine Journal , cilt.15, sa.12, ss.2509-2517, 2015 (SCI-Expanded, Scopus)

84. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women

Tekin Koruk S., BATIREL A., KÖSE Ş., AKHAN S., AYGEN B., Tulek N., et al.
Journal of Obstetrics and Gynaecology Research , cilt.41, sa.12, ss.1870-1876, 2015 (SCI-Expanded, Scopus)

85. The course of spinal tuberculosis (Pott disease): Results of the multinational, multicentre Backbone-2 study

BATIREL A., ERDEM H., Sengoz G., Pehlivanoglu F., Ramosaco E., Gülsün S., et al.
Clinical Microbiology and Infection , cilt.21, sa.11, 2015 (SCI-Expanded, Scopus)

86. Predictors for limb loss among patient with diabetic foot infections: An observational retrospective multicentric study in Turkey

SALTOĞLU N., Yemisen M., Ergonul O., Kadanali A., Karagoz G., BATIREL A., et al.
Clinical Microbiology and Infection , cilt.21, sa.7, ss.659-664, 2015 (SCI-Expanded, Scopus)

87. The knowledge of the physicians about sepsis bundles is suboptimal: A multicenter survey

Tufan Z. K., ESER F., Vudali E., BATIREL A., Kayaaslan B., BAŞTUĞ A., et al.
Journal of Clinical and Diagnostic Research , cilt.9, sa.7, 2015 (Scopus)

88. The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study

Arslan F., Meynet E., Sunbul M., Sipahi O., Kurtaran B., KAYA S., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.34, sa.6, ss.1213-1221, 2015 (SCI-Expanded, Scopus)

89. Tuberculous and brucellosis meningitis differential diagnosis

ERDEM H., ŞENBAYRAK S., Gencer S., Hasbun R., Karahocagil M. K., Sengoz G., et al.
Travel Medicine and Infectious Disease , cilt.13, sa.2, ss.185-191, 2015 (SCI-Expanded, Scopus)

90. Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A multicenter retrospective analysis

BALKAN İ. İ., BATIREL A., Karabay O., Agalar C., Akalin S., Alici O., et al.
Indian Journal of Pharmacology , cilt.47, sa.1, ss.95-100, 2015 (SCI-Expanded, Scopus)

91. Evaluation of tularaemia courses: A multicentre study from Turkey

ERDEM H., ÖZTÜRK ENGİN D., YEŞİLYURT M. K., Karabay O., ELALDI N., Celebi G., et al.
Clinical Microbiology and Infection , cilt.20, sa.12, 2014 (SCI-Expanded, Scopus)

92. Comment on: Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

Karabay O., BATIREL A., BALKAN İ. İ.
Journal of Antimicrobial Chemotherapy , cilt.69, sa.11, ss.3167, 2014 (SCI-Expanded, Scopus)

93. Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naïve patients with chronic hepatitis B: A multicenter real-life study

BATIREL A., Guclu E., Arslan F., Kocak F., Karabay O., Ozer S., et al.
International Journal of Infectious Diseases , cilt.28, ss.153-159, 2014 (SCI-Expanded, Scopus)

94. Colistin nephrotoxicity increases with age

BALKAN İ. İ., DOĞAN M., DURDU B., BATIREL A., HAKYEMEZ İ. N., Cetin B., et al.
Scandinavian Journal of Infectious Diseases , cilt.46, sa.10, ss.678-685, 2014 (SCI-Expanded, Scopus)

95. Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations CLSI ve EUCAST Önerilerine Göre Genişlemiş Spektrumlu Beta-Laktamaz Üreten Escherichia coli ̄drar ̄zolatlarinda Fosfomisin Duyarliliʇi

Aktaş S. Ç., Gençer S., BATIREL A., Haciseyitoʇlu D., Özer S.
Mikrobiyoloji Bulteni , cilt.48, sa.4, ss.545-555, 2014 (SCI-Expanded, Scopus, TRDizin)

96. Liver involvement in patients with brucellosis: Results of the Marmara study

ÖZTÜRK ENGİN D., ERDEM H., Gencer S., KAYA Ş., Baran A. İ., BATIREL A., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.33, sa.7, ss.1253-1262, 2014 (SCI-Expanded, Scopus)

97. Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

BATIREL A., BALKAN İ. İ., Karabay O., Agalar C., Akalin S., Alici O., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.33, sa.8, ss.1311-1322, 2014 (SCI-Expanded, Scopus)

98. Efficacy of colistin and non-colistin monotherapies in multi-drug resistant acinetobacter baumannii bacteremia/sepsis

Karabay O., BATIREL A., BALKAN İ. İ., Agalar C., Akalin S., Alici O., et al.
Acta Medica Mediterranea , cilt.30, sa.5, ss.1137-1143, 2014 (SCI-Expanded, Scopus)

99. A predisposing clinical condition for disseminated tuberculosis: Hairy cell leukemia Disemine Tüberküloz Için Predispozan Klinik Durum: Tüylü Hücreli Lösemi

Arslan F., BATIREL A., Özer S., Çaǧan Aktaş S.
Mikrobiyoloji Bulteni , cilt.47, sa.2, ss.346-350, 2013 (SCI-Expanded, Scopus, TRDizin)

100. Diagnosis of chronic brucellar meningitis and meningoencephalitis: The results of the Istanbul-2 study

ERDEM H., Kilic S., ŞENER B., Acikel C., ALP MEŞE E., Karahocagil M., et al.
Clinical Microbiology and Infection , cilt.19, sa.2, 2013 (SCI-Expanded, Scopus)

101. Imported Plasmodium falciparum malaria in Istanbul, Turkey: Risk factors for severe course and mortality

Arslan F., MERT A., BATIREL A., İNAN A., BALKAN İ. İ., Nazlican O., et al.
Tropical Doctor , cilt.43, sa.4, ss.129-133, 2013 (SCI-Expanded, Scopus)

102. Macrophage activation syndrome triggered by primary disseminated toxoplasmosis

Arslan F., BATIREL A., Ramazan M., Ozer S., MERT A.
Scandinavian Journal of Infectious Diseases , cilt.44, sa.12, ss.1001-1004, 2012 (SCI-Expanded, Scopus)

103. Fascioliasis: 3 Cases with three different clinical presentations

Arslan F., BATIREL A., Samasti M., Tabak F., MERT A., Özer S.
Turkish Journal of Gastroenterology , cilt.23, sa.3, ss.267-271, 2012 (SCI-Expanded, Scopus, TRDizin)

104. Cytomegalovirus (CMV)-related cutaneous necrotizing vasculitis: Case report and literature review

Arslan F., BATIREL A., MERT A., Ozer S.
Brazilian Journal of Infectious Diseases , cilt.16, sa.5, ss.482-485, 2012 (SCI-Expanded, Scopus)

105. Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: A prospecive cohort study

AK Ö., BATIREL A., Ozer S., Çolakoǧlu S.
Medical Science Monitor , cilt.17, sa.5, 2011 (Scopus)

106. Splenic abscess caused by MRSA developing in an infarcted area: Case report and literature review

Arslan F., BATIREL A., Tabak F., MERT A.
Journal of Infection and Chemotherapy , cilt.17, sa.6, ss.851-854, 2011 (SCI-Expanded, Scopus)

107. Hepatitis B virus seroprevalence in the pregnant population admitting to an education and research hospital in Istanbul İstanbul'da bi̇r eǧi̇ti̇m ve araştirma hastaneṡine başvuran gebelerde hepati̇t-B seroprevalansi

Api O., Bektaş M., Akil A., APİ M., BATIREL A., Bayer F., et al.
Turk Jinekoloji ve Obstetrik Dernegi Dergisi , cilt.6, sa.2, ss.103-110, 2009 (Scopus, TRDizin)

108. Angio-oedema as an unusual tolerable side effect of voriconazole therapy

Gençer S., Özer S., Demirhan G., AK Ö., BATIREL A.
Journal of Medical Microbiology , cilt.57, sa.8, ss.1028-1031, 2008 (SCI-Expanded, Scopus)

109. Transfusion associated graft-versus-host disease (TA-GVHD) in an immunocompetent patient following orthopedic surgery

BATIREL A., Özer S., Gençer S., Şeker M., Çetiner M., Egegül A., et al.
Marmara Medical Journal , cilt.19, sa.1, ss.36-40, 2006 (Scopus, TRDizin)

110. Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey

Gençer S., AK Ö., Benzonana N., BATIREL A., Özer S.
Annals of Clinical Microbiology and Antimicrobials , cilt.1, 2002 (Scopus)
Kitaplar 1

1. Tuberculous Spondylodiscitis

BATIREL A.
Extrapulmonary Tuberculosis, Springer International Publishing Ag, ss.83-99, 2019
Metrikler

Yayın

111

Yayın (WoS)

103

Yayın (Scopus)

111

H-İndeks (WoS)

23

Atıf (Scopus)

2118

H-İndeks (Scopus)

28

Atıf (TrDizin)

17

H-İndeks (TrDizin)

3

Atıf (Diğer Toplam)

17

Proje

1

Tez Danışmanlığı

13

Açık Erişim

15
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER